The strengths, weaknesses and predictive values of these three diagnostic modalities have been extensively studied [3-19], and their theoretical importances analyzed. Based on these studies, the ECG has been stated to be the most valuable test [4,5]. It is still unclear however,

just how these three diagnostic tools are used by ED physicians in their clinical reasoning, Inhibitors,research,lifescience,medical and which of them is the most important when physicians decide the likelihood of ACS. This study aimed to analyze, in routine ED care, the relative contributions of the symptoms, ECG and TnT to the physician’s assessment of the patient’s overall likelihood of ACS. Methods Setting The Skåne University Hospital at Lund is a 900 bed institution which serves as the primary hospital for some 290,000 inhabitants and has a cardiac intensive care unit with 19 beds. Percutaneous Inhibitors,research,lifescience,medical coronary intervention and coronary

bypass surgery are available 24 hours a day. There is a traditional ED with approximately 65000 patients per year with physician interns, residents and specialists in internal and emergency medicine. During the study period, there were no standardized management protocols for patients with possible ACS, and no dedicated chest pain unit. Standard practice was however Inhibitors,research,lifescience,medical to admit patients at low risk to telemetry at the intermediate care ward, and to admit those at high risk to the cardiac intensive care unit. A prehospital ECG system was in operation with ambulance ECGs sent to a Inhibitors,research,lifescience,medical cardiologist on call. If an ST elevation myocardial infarction was identified, the patient was transported directly to the angiography Inhibitors,research,lifescience,medical laboratory, bypassing

the ED. Patient inclusion and exclusion All patients aged over 18 years presenting with non-traumatic chest pain as the chief complaint to the Lund ED at Skåne University Hospital between June 12th and October 8th 2009 were Pexidartinib nmr prospectively screened for the study, and patients were included if the physician’s assessment L-NAME HCl verified that the patient’s chief compliant was chest pain. Ongoing chest pain was not required for inclusion. Patients not following the physician’s recommendation of in-hospital care were excluded, as were patients unable to give a clear symptom history due to e.g. alcohol intoxication or dementia, and those transferred to other hospitals for in-patient care. Patient numbers and causes of exclusion are shown in Figure 1. All included patients underwent a routine clinical evaluation in the ED including symptom history, physical exam, ECG and TnT. Figure 1 Patient flow chart. All included patients gave informed consent, and the study was approved by the regional ethics committee in Lund (DNR2009/630).